
Moderna, Inc (NASDAQ:MRNA) spiked up almost 5% off Friday’s closing price at one point on Monday, before hitting a resistance level at the $179 level and running into a group of sellers.
The pharmaceutical company has been trading in a strong uptrend on the weekly chart since June 13, although on the daily chart the uptrend has been less consistent.